KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like CARsgen Therapeutics Joins The Alliance For Regenerative Medicine June 29, 2017 Alimera Sciences To Report Second Quarter 2017 Financial Results On August 2nd, 2017 July 23, 2017 Billionaire Insys Founder Charged With Bribing Doctors to Prescribe Opioid Painkillers October 26, 2017
Billionaire Insys Founder Charged With Bribing Doctors to Prescribe Opioid Painkillers October 26, 2017
